TBIQYR4288-Global Home Use Lancing Devices Market Research Report 2019

                                          
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The lancing device is a convenient medical tool for collecting capillary blood samples for glucose monitoring or other tests requiring one or two drops of blood. It is dedicated for home diagnostics and aimed to be used by patients when performing skin puncture on them. A convenient and effortless device specially designed for the highest comfort in daily diabetes management.

In the last several years, global market of Lancing device developed year by year, with an average growth rate of 5.5% for the sales. In 2016, global revenue of lancing device is nearly 270 M USD; the sale is about 47.2 million units.

In the next few years, Lancing device industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Lancing device includes Adjustable Lancing Device, Non-adjustable Lancing Device. The proportion of Adjustable Lancing Device in 2016 is about 94%, and the proportion is increasing trend from 2012 to 2016. 

Lancing device is widely used in cholesterol tests, glucose tests and other tests. The more than half of lancing device is used in glucose test, and the sales proportion in 2016 is about 70%, but the Lancing device used in cholesterol test is enjoying more and more market share.

North America and Europe is the main consumption places, with a consumption market share nearly 41.7% and 27.6% in 2016. Other regions also enjoy the major market share in global region. 

Market competition is intense. Roche, LifeScan, Abbott, Ascensia, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. With the development of society and the changing of consumer demand, the Lancing device industry will be more and more popular in the future.



The global Home Use Lancing Devices market is valued at 270 million US$ in 2018 is expected to reach 410 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2019-2025.
This report focuses on Home Use Lancing Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Home Use Lancing Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Roche
    LifeScan
    Abbott
    Ascensia
    B. Braun
    Terumo
    ARKRAY
    Trividia Health
    SANNUO
    GMMC
    BIONIME

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Adjustable Lancing Device
    Non-adjustable Lancing Device

Segment by Application
    Cholesterol Tests
    Glucose Tests
    Others